Centro de Atención e Investigación Médica

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Bioequivalence Study of Revolade® Eltrombopag 50 mg	Healthy; Healthy Donors	Active, not recruiting	Phase 4	2025-06-19		NCT06834451

Clinical trials